HeartBeam (NASDAQ: BEAT) announced it has completed patient enrollment ahead of schedule in its ALIGN-ACS pilot study ...
Wearables now flag everything from irregular heartbeats to dips in blood oxygen, but the data is only as useful as a person's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results